top of page
Blog
He’s setting the world of Inflammation and Immunology research on fire!
Today we are honored to have Dr. Josep Bassaganya-Riera, President and CEO of NImmune Biopharma , to talk about how his company is...
tim78593
5 days ago2 min read
14 views
0 comments
Patient Advocacy is NOT optional!
In this podcast, we are pleased to have Mike Walsh, CEO of Patient Advocacy Strategies as our guest. Patient advocacy may seem like a...
tim78593
Mar 192 min read
22 views
0 comments
Taming the Behemoth of Adverse Drug Reactions with Zach Brooks
It’s shocking that 106,000 people die every year from adverse drug reactions. Moreover, 350,000 people are hospitalized every year, 1.3...
tim78593
Feb 122 min read
23 views
0 comments
A cup of Kombucha that ignited the war on sugar addiction
In this episode, filed at Science Square in Atlanta, we speak with David Francis  and Mighten Yip  of Palate Therapeutics , whose mission...
tim78593
Jan 152 min read
6 views
0 comments
Shooting for the Stars with Astrocyte Pharmaceuticals
With over 1.5 million people suffering traumatic brain injuries a year, 800,000 stroke victims, and millions of concussions, the impact...
tim78593
Dec 18, 20242 min read
18 views
0 comments
Knee-deep in meniscus redesign: the story of Atlanta’s OrthoPreserve
There are 1.4 million meniscus procedures performed in the US and Europe every single year. Most of those are meniscetomy which is when...
tim78593
Nov 20, 20242 min read
36 views
0 comments
Confronting the task of delivering scalable amounts of protein to a billion cows
Our guest today is Dr. Ivan Liachko, the CEO of Seattle-based Phase Genomics , a company whose core technology is ultra-long genome...
tim78593
Oct 16, 20242 min read
27 views
0 comments
What Pharma really thinks about Startups
Tune in for this insightful podcast with David Weinstock , the Vice President of Discovery Oncology at Merck, to find out what pharma...
tim78593
Aug 14, 20241 min read
89 views
0 comments
Meet the Reluctant Founder who is waging war on Antibiotic Resistant Infections!
Our guest today is another Atlanta luminary, Dr. Marvin Whiteley, the founder and CSO of SynthBiome, Inc. Deaths are expected to increase...
tim78593
Jul 10, 20242 min read
24 views
0 comments
How this founder raised $230MM in capital
Carter Cliff comes across, to nearly all who meet him, as a humble and soft-spoken scientist. You would never guess that he is a...
tim78593
Jun 12, 20242 min read
52 views
0 comments
Targeting the Ribosome: taking on platinum resistance in solid ovarian tumors in a safer way!
Today we’ve got Dr. Jonathan Arambula and Dr. Krystle Karoscik of InnovoTex, an oncology therapeutics company developing a platform of...
tim78593
May 15, 20243 min read
16 views
0 comments
Price controls for medicine – a chilling effect for innovators?
We’re going to talk with Peter Pitts, President of Center for Medicine in the Public Interest, about the IRA, which is impacting every...
tim78593
Apr 17, 20242 min read
10 views
0 comments
How to get funding for your biotech: what investors look for
According to Carta, in the first quarter of 2023, the median seed valuation for biotech and pharma rose 33% from the same quarter in the...
tim78593
Mar 20, 20242 min read
149 views
0 comments
Finding a cure for the neglected diseases of the world’s poor: an interview with drug discovery superstar Dr. Dennis Liotta
Dr. Dennis Liotta is very humble but don’t let that fool you – underneath the poised demeanor he’s a impassioned drug discovery giant who...
tim78593
Feb 14, 20242 min read
51 views
0 comments
Atlanta life sciences companies in OVERDRIVE: don’t sleep on ‘em!
Today we have four very special guests, some friends of mine, who are going to share with us the story behind all the momentum driving...
tim78593
Jan 17, 20245 min read
121 views
0 comments
Making vaccine delivery as simple as the flick of a lighter
Our guest today is Gaurav Byagathvalli, a Geoge Tech alum and the CEO of Piezo Therapeurtics, a company developing an innovative nucleic...
tim78593
Dec 13, 20232 min read
18 views
0 comments
Conquering the Disease State with Nolan Townsend
Our guest today is Nolan Townsend, the CEO of LEXEO Therapeutics, which focused on expanding the application of crisper gene therapies...
tim78593
Nov 8, 20232 min read
14 views
0 comments
The problem with how people take their medications
Today I am really excited to have Charles Gellman, CEO of HiDO Health. HiDO is a company that is focused on using artificial intelligence...
tim78593
Oct 11, 20232 min read
15 views
0 comments
Pills are not the only solution to big pain! With Dr. Amy Baxter
Our guest today is Dr. Amy Baxter, the CEO of Pain Care Labs, a company dedicated to using mechanical platforms such as vibrating devices...
tim78593
Sep 13, 20232 min read
16 views
0 comments
Mastering the Single Use Scope: the story of Xenocor
Today we are joined by Charles DeCoster, CEO, and Tony Watson, COO, of Xenocor, a company that is revolutionizing laparoscopic surgery...
tim78593
Aug 16, 20232 min read
35 views
0 comments
The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative.
Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
bottom of page